{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T04:57:10Z","timestamp":1790571430689,"version":"4.1.0"},"reference-count":236,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Jiangsu Province Natural Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.bbcan.2026.189723","type":"journal-article","created":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T15:29:10Z","timestamp":1790263750000},"page":"189723","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Tertiary lymphoid structures for anti-tumor immunotherapy"],"prefix":"10.1016","volume":"1881","author":[{"given":"Lin","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hualong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Zha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhilin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbcan.2026.189723_bb0005","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1477980","article-title":"Integrating immunotherapy with conventional treatment regime for breast cancer patients-an amalgamation of armamentarium","volume":"15","author":"Nandi","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2026.189723_bb0010","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1126\/science.1203486","article-title":"Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion","volume":"331","author":"Schreiber","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.bbcan.2026.189723_bb0015","doi-asserted-by":"crossref","DOI":"10.1038\/s41421-023-00568-6","article-title":"PPAR\u03b4 inhibition blocks the induction and function of tumor-induced IL-10+ regulatory B cells and enhances cancer immunotherapy","volume":"9","author":"Chen","year":"2023","journal-title":"Cell Discov."},{"key":"10.1016\/j.bbcan.2026.189723_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbe.2025.100005","article-title":"Engineered exosome based immunomodulation therapies: advancements and clinical applications","volume":"18","author":"Qazi","year":"2026","journal-title":"Nano Biomed. Eng."},{"key":"10.1016\/j.bbcan.2026.189723_bb0025","article-title":"Normalization of tumor blood vessels boosted the chemoimmunotherapy of glioblastoma","author":"Gu","year":"2026","journal-title":"Sustain. Mater. Technol."},{"key":"10.1016\/j.bbcan.2026.189723_bb0030","article-title":"A dual immunotherapy nanoparticle improves T-cell activation and cancer immunotherapy","volume":"30","author":"Mi","year":"2018","journal-title":"Adv. Mater."},{"key":"10.1016\/j.bbcan.2026.189723_bb0035","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1126\/science.3489291","article-title":"A new approach to the adoptive immunotherapy of Cancer with tumor-infiltrating lymphocytes","volume":"233","author":"Rosenberg","year":"1986","journal-title":"Science"},{"key":"10.1016\/j.bbcan.2026.189723_bb0040","doi-asserted-by":"crossref","first-page":"10024","DOI":"10.1073\/pnas.86.24.10024","article-title":"Expression of immunoglobulin-T-cell receptor chimeric molecules as functional receptors with antibody-type specificity","volume":"86","author":"Gross","year":"1989","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbcan.2026.189723_bb0045","article-title":"Targeted enhancement of antigen cross-presentation capability of M2-like tumor-associated macrophages to boost glioblastoma immunotherapy","author":"Jiang","year":"2025","journal-title":"Biomaterials"},{"key":"10.1016\/j.bbcan.2026.189723_bb0050","doi-asserted-by":"crossref","first-page":"23001","DOI":"10.1021\/acsnano.4c04553","article-title":"Boost infiltration and activity of T cells via inhibiting Ecto-5\u2032-nucleotidase (CD73) immune checkpoint to enhance glioblastoma immunotherapy","volume":"18","author":"Zhang","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.bbcan.2026.189723_bb0055","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1146\/annurev.immunol.26.021607.090257","article-title":"Development of secondary lymphoid organs","volume":"26","author":"Randall","year":"2008","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.bbcan.2026.189723_bb0060","doi-asserted-by":"crossref","first-page":"6333","DOI":"10.1021\/acsnano.3c11189","article-title":"Antigen self-presented personalized Nanovaccines boost the immunotherapy of highly invasive and metastatic Tumors","volume":"18","author":"Wang","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.bbcan.2026.189723_bb0065","first-page":"418","article-title":"Biomimetic nanoparticles directly remodel immunosuppressive microenvironment for boosting glioblastoma immunotherapy","volume":"16","author":"Wang","year":"2022","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.bbcan.2026.189723_bb0070","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1084\/jem.20160951","article-title":"DC subset\u2013specific induction of T cell responses upon antigen uptake via Fc\u03b3 receptors in vivo","volume":"214","author":"Lehmann","year":"2017","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbcan.2026.189723_bb0075","article-title":"Reversing T cell dysfunction to boost glioblastoma immunotherapy by paroxetine-mediated GRK2 inhibition and blockade of multiple checkpoints through biomimetic nanoparticles","volume":"10","author":"Wang","year":"2023","journal-title":"Adv. Sci."},{"key":"10.1016\/j.bbcan.2026.189723_bb0080","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1164\/rccm.201309-1611OC","article-title":"Presence of B cells in tertiary lymphoid structures is associated with a protective immunity in patients with lung cancer","volume":"189","author":"Germain","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.bbcan.2026.189723_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbe.2025.100038","article-title":"The application of nanomaterials in vaccine adjuvants","volume":"18","author":"Su","year":"2026","journal-title":"Nano Biomed. Eng."},{"key":"10.1016\/j.bbcan.2026.189723_bb0090","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.724739","article-title":"Tertiary lymphoid structures in the central nervous system: implications for glioblastoma","volume":"12","author":"van de Walle","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2026.189723_bb0095","article-title":"Initiation of tertiary lymphoid structures for cancer immunotherapy","volume":"25","author":"Zou","year":"2026","journal-title":"Research"},{"key":"10.1016\/j.bbcan.2026.189723_bb0100","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/s41568-024-00728-0","article-title":"Tertiary lymphoid structures in anticancer immunity","volume":"24","author":"Teillaud","year":"2024","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbcan.2026.189723_bb0105","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2016.00244","article-title":"Tertiary lymphoid organs in cancer tissues","volume":"7","author":"Hiraoka","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2026.189723_bb0110","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1126\/science.abf9419","article-title":"Tertiary lymphoid structures in cancer","volume":"375","author":"Schumacher","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.bbcan.2026.189723_bb0115","doi-asserted-by":"crossref","first-page":"6391","DOI":"10.1158\/0008-5472.CAN-11-0952","article-title":"Characterization of chemokines and adhesion molecules associated with T cell presence in tertiary lymphoid structures in human lung cancer","volume":"71","author":"de Chaisemartin","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189723_bb0120","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1158\/0008-5472.CAN-13-1342","article-title":"Dendritic cells in tumor-associated tertiary lymphoid structures signal a Th1 cytotoxic immune contexture and license the positive prognostic value of infiltrating CD8+ T cells","volume":"74","author":"Goc","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189723_bb0125","doi-asserted-by":"crossref","first-page":"4410","DOI":"10.1200\/JCO.2007.15.0284","article-title":"Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures","volume":"26","author":"Dieu-Nosjean","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2026.189723_bb0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers4010001","article-title":"Tertiary intratumor lymphoid tissue in colo-rectal cancer","volume":"4","author":"Bergomas","year":"2012","journal-title":"Cancers"},{"key":"10.1016\/j.bbcan.2026.189723_bb0135","doi-asserted-by":"crossref","first-page":"5678","DOI":"10.1158\/0008-5472.CAN-11-0431","article-title":"Human solid tumors contain high endothelial venules: association with T- and B-lymphocyte infiltration and favorable prognosis in breast cancer","volume":"71","author":"Martinet","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189723_bb0140","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ajpath.2011.03.007","article-title":"Unique ectopic lymph node-like structures present in human primary colorectal carcinoma are identified by immune gene Array profiling","volume":"179","author":"Coppola","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbcan.2026.189723_bb0145","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1007\/s00262-019-02407-8","article-title":"The prognostic significance of peritumoral tertiary lymphoid structures in breast cancer","volume":"68","author":"Sofopoulos","year":"2019","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.bbcan.2026.189723_bb0150","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/s41568-019-0144-6","article-title":"Tertiary lymphoid structures in the era of cancer immunotherapy","volume":"19","author":"Sautes-Fridman","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbcan.2026.189723_bb0155","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1084\/jem.183.4.1461","article-title":"Chronic inflammation caused by lymphotoxin is lymphoid neogenesis","volume":"183","author":"Kratz","year":"1996","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbcan.2026.189723_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2022.101703","article-title":"Activation of B cells in tertiary lymphoid structures in cancer: anti-tumor or anti-self?","volume":"65","author":"Fridman","year":"2023","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.bbcan.2026.189723_bb0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0224430","article-title":"The prognostic significance of tumor-infiltrating lymphocytes assessment with hematoxylin and eosin sections in resected primary lung adenocarcinoma","volume":"14","author":"Kim","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.bbcan.2026.189723_bb0170","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.canlet.2019.02.027","article-title":"BRCA gene mutations do not shape the extent and organization of tumor infiltrating lymphocytes in triple negative breast cancer","volume":"450","author":"Solinas","year":"2019","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbcan.2026.189723_bb0175","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1038\/s41590-024-01992-w","article-title":"Immunotherapy response induces divergent tertiary lymphoid structure morphologies in hepatocellular carcinoma","volume":"25","author":"Shu","year":"2024","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bbcan.2026.189723_bb0180","doi-asserted-by":"crossref","first-page":"14424","DOI":"10.1038\/s41598-021-93807-3","article-title":"HLA-DR cancer cells expression correlates with T cell infiltration and is enriched in lung adenocarcinoma with indolent behavior","volume":"11","author":"Senosain","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbcan.2026.189723_bb0185","first-page":"1179","article-title":"The future of tertiary lymphoid structures in cancer immunotherapy as biomarkers and therapeutic targets","volume":"9","author":"Kim","year":"2026","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.bbcan.2026.189723_bb0190","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/s41586-019-1914-8","article-title":"Tertiary lymphoid structures improve immunotherapy and survival in melanoma","volume":"577","author":"Cabrita","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2026.189723_bb0195","doi-asserted-by":"crossref","first-page":"7194","DOI":"10.1021\/acsnano.2c09619","article-title":"Nanovaccines fostering tertiary lymphoid structure to attack mimicry nasopharyngeal carcinoma","volume":"17","author":"Wen","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.bbcan.2026.189723_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2025.123166","article-title":"Hierarchical protein nano-crystalline hydrogel with extracellular vesicles for ectopic lymphoid structure formation","volume":"318","author":"Ahn","year":"2025","journal-title":"Biomaterials"},{"key":"10.1016\/j.bbcan.2026.189723_bb0205","doi-asserted-by":"crossref","first-page":"91","DOI":"10.26599\/NBE.2025.9290117","article-title":"Versatile copper-chalcogenide-based nanoparticles for the treatment of brain diseases","volume":"17","author":"Xie","year":"2025","journal-title":"Nano Biomed. Eng."},{"key":"10.1016\/j.bbcan.2026.189723_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbe.2025.100002","article-title":"Design of nanomaterials for enhanced cancer immunotherapy: a review","volume":"18","author":"Shi","year":"2026","journal-title":"Nano Biomed. Eng."},{"key":"10.1016\/j.bbcan.2026.189723_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2025.189393","article-title":"Advances in the combination of immunoadjuvants and tumor ablation: mediating immune effects to enhance anti-tumor efficacy","volume":"1880","author":"Yu","year":"2025","journal-title":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"},{"key":"10.1016\/j.bbcan.2026.189723_bb0220","article-title":"Neoantigen-driven personalized vaccines for breast cancer: platforms, nano-delivery systems, and combination strategies","author":"Liu","year":"2026","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"key":"10.1016\/j.bbcan.2026.189723_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216293","article-title":"Tertiary lymphoid structures and cytokines interconnections: the implication in cancer immunotherapy","volume":"568","author":"Li","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbcan.2026.189723_bb0230","article-title":"Tertiary lymphoid structures: new immunotherapy biomarker","volume":"15","author":"Yang","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2026.189723_bb0235","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.it.2012.04.006","article-title":"Tertiary lymphoid organs in infection and autoimmunity","volume":"33","author":"Neyt","year":"2012","journal-title":"Trends Immunol."},{"key":"10.1016\/j.bbcan.2026.189723_bb0240","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.0105-2896.2009.00861.x","article-title":"Secondary and ectopic lymphoid tissue responses in rheumatoid arthritis: from inflammation to autoimmunity and tissue damage\/remodeling","volume":"233","author":"Manzo","year":"2010","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.bbcan.2026.189723_bb0245","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2016.00407","article-title":"Tertiary lymphoid structures in cancers: prognostic value, regulation, and manipulation for therapeutic intervention","volume":"7","author":"Saut\u00e8s-Fridman","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2026.189723_bb0250","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.01830","article-title":"Tertiary lymphoid structures in cancer: drivers of antitumor immunity, immunosuppression, or bystander sentinels in disease?","volume":"8","author":"Colbeck","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2026.189723_bb0255","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1158\/0008-5472.CAN-17-1987","article-title":"Germinal Centers determine the prognostic relevance of tertiary lymphoid structures and are impaired by corticosteroids in lung squamous cell carcinoma","volume":"78","author":"Sili\u0146a","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189723_bb0260","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1158\/1078-0432.CCR-13-2590","article-title":"Occurrence of tertiary lymphoid tissue is associated with T-cell infiltration and predicts better prognosis in early-stage colorectal cancers","volume":"20","author":"Di Caro","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189723_bb0265","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s10456-021-09792-8","article-title":"High endothelial venules (HEVs) in immunity, inflammation and cancer","volume":"24","author":"Blanchard","year":"2021","journal-title":"Angiogenesis"},{"key":"10.1016\/j.bbcan.2026.189723_bb0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2025.189500","article-title":"Tumor-associated high endothelial venules as therapeutic modulation targets in cancer immunotherapy","volume":"1880","author":"Zhang","year":"2025","journal-title":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"},{"key":"10.1016\/j.bbcan.2026.189723_bb0275","doi-asserted-by":"crossref","DOI":"10.1172\/JCI171310","article-title":"Discovering the fibroblastic reticular cell in the immune tumor microenvironment in lymphoma","volume":"133","author":"Lin","year":"2023","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbcan.2026.189723_bb0280","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/imr.12748","article-title":"Fibroblastic reticular cells at the nexus of innate and adaptive immune responses","volume":"289","author":"Perez-Shibayama","year":"2019","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.bbcan.2026.189723_bb0285","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1172\/JCI71611","article-title":"Lymphatic vessels and tertiary lymphoid organs","volume":"124","author":"Ruddle","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbcan.2026.189723_bb0290","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/s41392-024-01947-5","article-title":"Tertiary lymphoid structures in diseases: immune mechanisms and therapeutic advances","volume":"9","author":"Zhao","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bbcan.2026.189723_bb0295","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/nri1054","article-title":"Organogenesis of lymphoid tissues","volume":"3","author":"Mebius","year":"2003","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbcan.2026.189723_bb0300","doi-asserted-by":"crossref","DOI":"10.1186\/s40364-026-00939-7","article-title":"The formation and function of tertiary lymphoid structures","volume":"14","author":"Zhang","year":"2026","journal-title":"Biomark. Res."},{"key":"10.1016\/j.bbcan.2026.189723_bb0305","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/j.jcmgh.2021.06.023","article-title":"Pancreatic cancer chemotherapy is potentiated by induction of tertiary lymphoid structures in mice","volume":"12","author":"Delvecchio","year":"2021","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbcan.2026.189723_bb0310","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aax7992","article-title":"Intratumoral expression of IL-7 and IL-12 using an oncolytic virus increases systemic sensitivity to immune checkpoint blockade","volume":"12","author":"Nakao","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bbcan.2026.189723_bb0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112924","article-title":"Transcription factor TCF-1 regulates the functions, but not the development, of lymphoid tissue inducer subsets in different tissues","volume":"42","author":"Zheng","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbcan.2026.189723_bb0320","doi-asserted-by":"crossref","first-page":"5344","DOI":"10.4049\/jimmunol.0902999","article-title":"Intragraft Th17 infiltrate promotes lymphoid neogenesis and hastens clinical chronic rejection","volume":"184","author":"Deteix","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbcan.2026.189723_bb0325","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.immuni.2011.10.015","article-title":"Th17 cells induce ectopic lymphoid follicles in central nervous system tissue inflammation","volume":"35","author":"Peters","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.bbcan.2026.189723_bb0330","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1084\/jem.20100052","article-title":"Microbiota-induced tertiary lymphoid tissues aggravate inflammatory disease in the absence of ROR\u03b3t and LTi cells","volume":"208","author":"Lochner","year":"2011","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbcan.2026.189723_bb0335","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1093\/cvr\/cvt263","article-title":"M1 macrophages act as LT\u03b2R-independent lymphoid tissue inducer cells during atherosclerosis-related lymphoid neogenesis","volume":"101","author":"Guedj","year":"2014","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bbcan.2026.189723_bb0340","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/BF02786481","article-title":"Lymphoid neoorganogenesis","volume":"19","author":"Ruddle","year":"1999","journal-title":"Immunol. Res."},{"key":"10.1016\/j.bbcan.2026.189723_bb0345","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1126\/science.8171322","article-title":"Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin","volume":"264","author":"De Togni","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.bbcan.2026.189723_bb0350","doi-asserted-by":"crossref","DOI":"10.1111\/imr.70062","article-title":"From lymphotoxin to tertiary lymphoid structures and beyond","volume":"335","author":"Ruddle","year":"2025","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.bbcan.2026.189723_bb0355","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1038\/s41418-021-00834-8","article-title":"Lymphotoxin: from the physiology to the regeneration of the thymic function","volume":"28","author":"Borelli","year":"2021","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bbcan.2026.189723_bb0360","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/s41419-021-03633-8","article-title":"Membrane lymphotoxin-\u03b12\u03b2 is a novel tumor necrosis factor (TNF) receptor 2 (TNFR2) agonist","volume":"12","author":"Kucka","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbcan.2026.189723_bb0365","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1084\/jem.184.5.1999","article-title":"Surface lymphotoxin alpha\/beta complex is required for the development of peripheral lymphoid organs","volume":"184","author":"Rennert","year":"1996","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbcan.2026.189723_bb0370","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.molmed.2024.10.014","article-title":"Tertiary lymphoid structures in the central nervous system","volume":"31","author":"Yang","year":"2025","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.bbcan.2026.189723_bb0375","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1084\/jem.189.2.403","article-title":"Lymphotoxin \u03b1\/\u03b2 and tumor necrosis factor are required for stromal cell expression of homing chemokines in B and T cell areas of the spleen","volume":"189","author":"Ngo","year":"1999","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbcan.2026.189723_bb0380","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1106434","article-title":"Tumor immune microenvironment of cutaneous angiosarcoma with cancer testis antigens and the formation of tertiary lymphoid structures","volume":"13","author":"Magara","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbcan.2026.189723_bb0385","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-46873-w","article-title":"Tertiary lymphoid structures and B cells determine clinically relevant T cell phenotypes in ovarian cancer","volume":"15","author":"Kasikova","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2026.189723_bb0390","doi-asserted-by":"crossref","first-page":"5851","DOI":"10.4049\/jimmunol.170.12.5851","article-title":"Proliferation and survival of activated B cells requires sustained antigen receptor engagement and phosphoinositide 3-kinase activation","volume":"170","author":"Donahue","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbcan.2026.189723_bb0395","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.671258","article-title":"Protection of antigen-primed effector T cells from glucocorticoid-induced apoptosis in cell culture and in a mouse model of multiple sclerosis","volume":"12","author":"Bier","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2026.189723_bb0400","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2016.00225","article-title":"How follicular dendritic cells shape the B-cell antigenome","volume":"7","author":"Kranich","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2026.189723_bb0405","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1158\/2159-8290.CD-20-0522","article-title":"Tumor mutational burden as a predictive biomarker in solid Tumors","volume":"10","author":"Sha","year":"2020","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bbcan.2026.189723_bb0410","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1093\/annonc\/mdy495","article-title":"Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic","volume":"30","author":"Chan","year":"2019","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.bbcan.2026.189723_bb0415","doi-asserted-by":"crossref","DOI":"10.1111\/imr.70046","article-title":"The sunrise of tertiary lymphoid structures in cancer","volume":"332","author":"Rochefort","year":"2025","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.bbcan.2026.189723_bb0420","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.semcancer.2025.09.005","article-title":"Microorganisms in cancer tertiary lymphoid structure formation","volume":"116","author":"Li","year":"2025","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.bbcan.2026.189723_bb0425","article-title":"Exploring effects of gut microbiota on tertiary lymphoid structure formation for tumor immunotherapy","volume":"15","author":"Liu","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2026.189723_bb0430","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1289753","article-title":"The enrichment of the gut microbiota Lachnoclostridium is associated with the presence of intratumoral tertiary lymphoid structures in hepatocellular carcinoma","volume":"14","author":"Zhao","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2026.189723_bb0435","article-title":"590\u00a0metagenomic sequencing reveals unique gut microbial features associated with tertiary lymphoid structures in response to immune checkpoint blockade in solid cancers","volume":"10","author":"Chelvanambi","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.bbcan.2026.189723_bb0440","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jtho.2025.09.506","article-title":"P2.02.35 association of intratumoral microbiota composition with tertiary lymphatic structure of lung adenocarcinoma","volume":"20","author":"Zhou","year":"2025","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.bbcan.2026.189723_bb0445","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1126\/science.aay9189","article-title":"The human tumor microbiome is composed of tumor type\u2013specific intracellular bacteria","volume":"368","author":"Nejman","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.bbcan.2026.189723_bb0450","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/j.cell.2022.02.027","article-title":"Tumor-resident intracellular microbiota promotes metastatic colonization in breast cancer","volume":"185","author":"Fu","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2026.189723_bb0455","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1016\/j.immuni.2021.11.003","article-title":"Microbiota-specific T follicular helper cells drive tertiary lymphoid structures and anti-tumor immunity against colorectal cancer","volume":"54","author":"Overacre-Delgoffe","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.bbcan.2026.189723_bb0460","doi-asserted-by":"crossref","DOI":"10.1126\/science.adz2742","article-title":"Pan-cancer spatial atlas of tertiary lymphoid structures","volume":"392","author":"Cho","year":"2026","journal-title":"Science"},{"key":"10.1016\/j.bbcan.2026.189723_bb0465","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.immuni.2015.08.006","article-title":"Regulatory T cells in tumor-associated tertiary lymphoid structures suppress anti-tumor T cell responses","volume":"43","author":"Joshi","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.bbcan.2026.189723_bb0470","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1172\/JCI67428","article-title":"CD4+ follicular helper T cell infiltration predicts breast cancer survival","volume":"123","author":"Gu-Trantien","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbcan.2026.189723_bb0475","doi-asserted-by":"crossref","DOI":"10.1172\/JCI139905","article-title":"Functional Th1-oriented T follicular helper cells that infiltrate human breast cancer promote effective adaptive immunity","volume":"131","author":"No\u00ebl","year":"2021","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbcan.2026.189723_bb0480","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-002101","article-title":"PD-1+ CXCR5\u2212 CD4+ Th-CXCL13 cell subset drives B cells into tertiary lymphoid structures of nasopharyngeal carcinoma","volume":"9","author":"Li","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.bbcan.2026.189723_bb0485","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1158\/1078-0432.CCR-15-2762","article-title":"Tumor-infiltrating plasma cells are associated with tertiary lymphoid structures, cytolytic T-cell responses, and superior prognosis in ovarian Cancer","volume":"22","author":"Kroeger","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189723_bb0490","article-title":"Tertiary lymphoid structures are critical for cancer prognosis and therapeutic response","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2026.189723_bb0495","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-29040-x","article-title":"Tertiary lymphoid structures critical for prognosis in endometrial cancer patients","volume":"13","author":"Horeweg","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2026.189723_bb0500","doi-asserted-by":"crossref","DOI":"10.1038\/s42003-022-04356-y","article-title":"Regulatory T cells infiltrate the tumor-induced tertiary lympho\u00efd structures and are associated with poor clinical outcome in NSCLC","volume":"5","author":"Devi-Marulkar","year":"2022","journal-title":"Commun. Biol."},{"key":"10.1016\/j.bbcan.2026.189723_bb0505","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.626776","article-title":"Tertiary lymphoid structure-B cells narrow regulatory T cells impact in lung cancer patients","volume":"12","author":"Germain","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2026.189723_bb0510","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/s41586-019-1922-8","article-title":"B cells and tertiary lymphoid structures promote immunotherapy response","volume":"577","author":"Helmink","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2026.189723_bb0515","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1093\/annonc\/mdy218","article-title":"Pathologic features of response to neoadjuvant anti-PD-1 in resected non-small-cell lung carcinoma: a proposal for quantitative immune-related pathologic response criteria (irPRC)","volume":"29","author":"Cottrell","year":"2018","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.bbcan.2026.189723_bb0520","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1038\/s41591-020-1085-z","article-title":"Preoperative ipilimumab plus nivolumab in locoregionally advanced urothelial cancer: the NABUCCO trial","volume":"26","author":"van Dijk","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbcan.2026.189723_bb0525","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.cell.2019.10.028","article-title":"B cells and T follicular helper cells mediate response to checkpoint inhibitors in high mutation burden mouse models of breast Cancer","volume":"179","author":"Hollern","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2026.189723_bb0530","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2025.189312","article-title":"Tertiary lymphoid structures achieve \u2018cold\u2019 to \u2018hot\u2019 transition by remodeling the cold tumor microenvironment","volume":"1880","author":"Cui","year":"2025","journal-title":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"},{"key":"10.1016\/j.bbcan.2026.189723_bb0535","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1322035","article-title":"Tertiary lymphoid structures in autoimmune diseases","volume":"14","author":"Dong","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2026.189723_bb0540","doi-asserted-by":"crossref","first-page":"9176","DOI":"10.1021\/acsnano.4c01180","article-title":"Biomimetic tertiary lymphoid structures with microporous annealed particle scaffolds for Cancer postoperative therapy","volume":"18","author":"Kuang","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.bbcan.2026.189723_bb0545","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1111\/cas.16371","article-title":"CXCL9 andCXCL13 shape endometrial cancer immune-activated microenvironment via tertiary lymphoid structure formation","volume":"116","author":"Nagase","year":"2025","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bbcan.2026.189723_bb0550","article-title":"Mechanistic basis of co-stimulatory CD40-CD40L ligation mediated regulation of immune responses in cancer and autoimmune disorders","volume":"225","author":"Dakal","year":"2020","journal-title":"Immunobiology"},{"key":"10.1016\/j.bbcan.2026.189723_bb0555","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.immuni.2022.02.001","article-title":"Tertiary lymphoid structures generate and propagate anti-tumor antibody-producing plasma cells in renal cell cancer","volume":"55","author":"Meylan","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.bbcan.2026.189723_bb0560","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2025-012224","article-title":"Tertiary lymphoid structures in Merkel cell carcinoma facilitate na\u00efve and central memory T-cell infiltration linked to immunotherapy response","volume":"13","author":"Srinivas","year":"2025","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.bbcan.2026.189723_bb0565","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105154","article-title":"T cell exhaustion initiates tertiary lymphoid structures and turbocharges cancer-immunity cycle","volume":"104","author":"Lin","year":"2024","journal-title":"EBioMedicine"},{"key":"10.1016\/j.bbcan.2026.189723_bb0570","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-29753-z","article-title":"T follicular helper and B cell crosstalk in tertiary lymphoid structures and cancer immunotherapy","volume":"13","author":"Garaud","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2026.189723_bb0575","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1053\/j.gastro.2023.10.022","article-title":"Tertiary lymphoid structure-associated B cells enhance CXCL13+ CD103+ CD8+ tissue-resident memory T-cell response to programmed cell death protein 1 blockade in cancer immunotherapy","volume":"166","author":"Hu","year":"2024","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbcan.2026.189723_bb0580","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/s41586-019-1906-8","article-title":"B cells are associated with survival and immunotherapy response in sarcoma","volume":"577","author":"Petitprez","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2026.189723_bb0585","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/s41568-023-00626-x","article-title":"Tertiary lymphoid structures as hubs of antitumour immunity","volume":"23","author":"Sarti Kinker","year":"2023","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbcan.2026.189723_bb0590","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2021.1915574","article-title":"Tertiary lymphoid structure signatures are associated with survival and immunotherapy response in muscle-invasive bladder cancer","volume":"10","author":"Zhou","year":"2021","journal-title":"OncoImmunology"},{"key":"10.1016\/j.bbcan.2026.189723_bb0595","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1158\/2326-6066.CIR-20-0432","article-title":"Insights into tumor-associated tertiary lymphoid structures: novel targets for antitumor immunity and cancer immunotherapy","volume":"8","author":"Rodriguez","year":"2020","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.bbcan.2026.189723_bb0600","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1007\/s00262-022-03310-5","article-title":"Intratumoral tertiary lymphoid structures promote patient survival and immunotherapy response in head neck squamous cell carcinoma","volume":"72","author":"Liu","year":"2023","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.bbcan.2026.189723_bb0605","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1038\/ni.3836","article-title":"De novo induction of intratumoral lymphoid structures and vessel normalization enhances immunotherapy in resistant tumors","volume":"18","author":"Johansson-Percival","year":"2017","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bbcan.2026.189723_bb0610","first-page":"1","article-title":"Tertiary lymphoid structures: allies of cancer immunotherapy","author":"Li","year":"2025","journal-title":"Immunology"},{"key":"10.1016\/j.bbcan.2026.189723_bb0615","article-title":"Tertiary lymphoid structures and cancer immunotherapy: from bench to bedside","volume":"6","author":"Peyraud","year":"2025","journal-title":"Medicine"},{"key":"10.1016\/j.bbcan.2026.189723_bb0620","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1016\/j.ymthe.2023.06.015","article-title":"LIGHT\/TNFSF14 promotes CAR-T cell trafficking and cytotoxicity through reversing immunosuppressive tumor microenvironment","volume":"31","author":"Zhang","year":"2023","journal-title":"Mol. Ther."},{"key":"10.1016\/j.bbcan.2026.189723_bb0625","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202407425","article-title":"Photo-metallo-immunotherapy: fabricating chromium-based nanocomposites to enhance CAR-T cell infiltration and cytotoxicity against solid tumors","volume":"37","author":"Zou","year":"2025","journal-title":"Adv. Mater."},{"key":"10.1016\/j.bbcan.2026.189723_bb0630","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.jhep.2024.12.040","article-title":"Tertiary lymphoid structure dynamics at the Centre of immunotherapy response in hepatocellular carcinoma","volume":"82","author":"Pinato","year":"2025","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbcan.2026.189723_bb0635","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1080\/1744666X.2024.2380892","article-title":"Tumor-associated tertiary lymphoid structures in cancer: implications for immunotherapy","volume":"20","author":"Langouo Fontsa","year":"2024","journal-title":"Expert Rev. Clin. Immunol."},{"key":"10.1016\/j.bbcan.2026.189723_bb0640","article-title":"Tertiary lymphoid structures validated as biomarker","volume":"14","year":"2024","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bbcan.2026.189723_bb0645","article-title":"584\u00a0therapeutic vascular normalization to promote tumor-associated tertiary lymphoid structures","volume":"8","author":"Filderman","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.bbcan.2026.189723_bb0650","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1038\/s12276-020-00500-y","article-title":"Combination of anti-angiogenic therapy and immune checkpoint blockade normalizes vascular-immune crosstalk to potentiate cancer immunity","volume":"52","author":"Lee","year":"2020","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.bbcan.2026.189723_bb0655","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1126\/science.aaw7875","article-title":"Vascular regulation of antitumor immunity","volume":"365","author":"Munn","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.bbcan.2026.189723_bb0660","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adr1299","article-title":"Intratumoral antigen-presenting cell activation by a nanovesicle for the concurrent tertiary lymphoid structure de novo neogenesis","volume":"11","author":"Cheng","year":"2025","journal-title":"Sci. Adv."},{"key":"10.1016\/j.bbcan.2026.189723_bb0665","doi-asserted-by":"crossref","first-page":"4350","DOI":"10.1172\/JCI125413","article-title":"STING activation reprograms tumor vasculatures and synergizes with VEGFR2 blockade","volume":"129","author":"Yang","year":"2019","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbcan.2026.189723_bb0670","doi-asserted-by":"crossref","first-page":"50277","DOI":"10.18632\/oncotarget.10364","article-title":"Sunitinib enhances the antitumor responses of agonistic CD40-antibody by reducing MDSCs and synergistically improving endothelial activation and T-cell recruitment","volume":"7","author":"van Hooren","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbcan.2026.189723_bb0675","doi-asserted-by":"crossref","DOI":"10.1177\/17588359221110176","article-title":"Tumor vessel normalization and immunotherapy in gastric cancer","volume":"14","author":"Yu","year":"2022","journal-title":"Ther. Adv. Med. Oncol."},{"key":"10.1016\/j.bbcan.2026.189723_bb0680","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/s41577-025-01187-w","article-title":"Tumour-associated vasculature in T cell homing and immunity: opportunities for cancer therapy","volume":"25","author":"Lanitis","year":"2025","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbcan.2026.189723_bb0685","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1126\/science.1104819","article-title":"Normalization of tumor vasculature: An emerging concept in antiangiogenic therapy","volume":"307","author":"Jain","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.bbcan.2026.189723_bb0690","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nrd3455","article-title":"Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases","volume":"10","author":"Carmeliet","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbcan.2026.189723_bb0695","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1056\/NEJMoa1915745","article-title":"Atezolizumab plus Bevacizumab in unresectable hepatocellular carcinoma","volume":"382","author":"Finn","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbcan.2026.189723_bb0700","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1056\/NEJMoa1716948","article-title":"Atezolizumab for first-line treatment of metastatic nonsquamous NSCLC","volume":"378","author":"Socinski","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbcan.2026.189723_bb0705","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S1074-7613(00)80199-5","article-title":"BLC expression in pancreatic islets causes B cell recruitment and lymphotoxin-dependent lymphoid neogenesis","volume":"12","author":"Luther","year":"2000","journal-title":"Immunity"},{"key":"10.1016\/j.bbcan.2026.189723_bb0710","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1002\/art.22939","article-title":"CXCR5\u2212 and CCR7\u2212dependent lymphoid neogenesis in a murine model of chronic antigen-induced arthritis","volume":"56","author":"Wengner","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bbcan.2026.189723_bb0715","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1084\/jem.20131737","article-title":"IL-17\u2013induced CXCL12 recruits B cells and induces follicle formation in BALT in the absence of differentiated FDCs","volume":"211","author":"Fleige","year":"2014","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbcan.2026.189723_bb0720","doi-asserted-by":"crossref","first-page":"424","DOI":"10.4049\/jimmunol.169.1.424","article-title":"Differing activities of homeostatic chemokines CCL19, CCL21, and CXCL12 in lymphocyte and dendritic cell recruitment and lymphoid neogenesis","volume":"169","author":"Luther","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbcan.2026.189723_bb0725","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/ni1456","article-title":"Interaction of the selectin ligand PSGL-1 with chemokines CCL21 and CCL19 facilitates efficient homing of T cells to secondary lymphoid organs","volume":"8","author":"Veerman","year":"2007","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bbcan.2026.189723_bb0730","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1084\/jem.20021761","article-title":"Ectopic LT\u03b1\u03b2 directs lymphoid organ neogenesis with concomitant expression of peripheral node Addressin and a HEV-restricted sulfotransferase","volume":"197","author":"Drayton","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbcan.2026.189723_bb0735","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aay7785","article-title":"Dual pH-sensitive nanodrug blocks PD-1 immune checkpoint and uses T cells to deliver NF-kappaB inhibitor for antitumor immunotherapy","volume":"6","author":"Xiao","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.bbcan.2026.189723_bb0740","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2018.00092","article-title":"Combination therapy with histone deacetylase inhibitors (HDACi) for the treatment of cancer: achieving the full therapeutic potential of HDACi","volume":"8","author":"Suraweera","year":"2018","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbcan.2026.189723_bb0745","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.629519","article-title":"Cutaneous melanoma: mutational status and potential links to tertiary lymphoid structure formation","volume":"12","author":"Salem","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2026.189723_bb0750","doi-asserted-by":"crossref","first-page":"4365","DOI":"10.1039\/D3MH00748K","article-title":"Engineering metal-based hydrogel-mediated tertiary lymphoid structure formationvia activation of the STING pathway for enhanced immunotherapy","volume":"10","author":"Jin","year":"2023","journal-title":"Mater. Horiz."},{"key":"10.1016\/j.bbcan.2026.189723_bb0755","doi-asserted-by":"crossref","first-page":"4127","DOI":"10.1038\/s41467-021-24347-7","article-title":"Agonistic CD40 therapy induces tertiary lymphoid structures but impairs responses to checkpoint blockade in glioma","volume":"12","author":"van Hooren","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2026.189723_bb0760","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ejca.2021.01.036","article-title":"Tertiary lymphoid structures marker CXCL13 is associated with better survival for patients with advanced-stage bladder cancer treated with immunotherapy","volume":"148","author":"Groeneveld","year":"2021","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.bbcan.2026.189723_bb0765","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/s41571-021-00507-y","article-title":"Intratumoural administration and tumour tissue targeting of cancer immunotherapies","volume":"18","author":"Melero","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2026.189723_bb0770","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrd.2017.243","article-title":"mRNA vaccines \u2014 a new era in vaccinology","volume":"17","author":"Pardi","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbcan.2026.189723_bb0775","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/s41586-020-2814-7","article-title":"COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses","volume":"586","author":"Sahin","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2026.189723_bb0780","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/nature15818","article-title":"Gene therapy returns to Centre stage","volume":"526","author":"Naldini","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2026.189723_bb0785","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/nri3700","article-title":"Ectopic lymphoid-like structures in infection, cancer and autoimmunity","volume":"14","author":"Pitzalis","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbcan.2026.189723_bb0790","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/s41590-022-01132-2","article-title":"Immunogenic cell stress and death","volume":"23","author":"Kroemer","year":"2022","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bbcan.2026.189723_bb0795","doi-asserted-by":"crossref","DOI":"10.1002\/sstr.202500452","article-title":"HA self-assembled dual-drug-loaded nanoparticles: integrating multitargeted tumor therapy and immune microenvironment remodeling via phototherapy and apoptosis","volume":"6","author":"Zang","year":"2025","journal-title":"Small Struct."},{"key":"10.1016\/j.bbcan.2026.189723_bb0800","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2026.189640","article-title":"Programming regulated cell death to engineer whole-tumor-cell vaccines for cancer immunotherapy","volume":"1881","author":"Guan","year":"2026","journal-title":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"},{"key":"10.1016\/j.bbcan.2026.189723_bb0805","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2026.189612","article-title":"Role of HMGB1 in tumors and its targeted therapy","volume":"1881","author":"Chu","year":"2026","journal-title":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"},{"key":"10.1016\/j.bbcan.2026.189723_bb0810","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1038\/s41388-021-01687-8","article-title":"Non-steroidal anti-inflammatory drugs induce immunogenic cell death in suppressing colorectal tumorigenesis","volume":"40","author":"Fletcher","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2026.189723_bb0815","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/s41418-020-00658-y","article-title":"The intrinsic immunogenic properties of cancer cell lines, immunogenic cell death, and how these influence host antitumor immune responses","volume":"28","author":"Aaes","year":"2021","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bbcan.2026.189723_bb0820","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1021\/acs.bioconjchem.4c00488","article-title":"Iron oxide nanoparticles induce macrophage secretion of ATP and HMGB1 to enhance irradiation-led immunogenic cell death","volume":"36","author":"Zhan","year":"2025","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.bbcan.2026.189723_bb0825","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1021\/acsnano.4c00654","article-title":"Tumor vaccine exploiting membranes with influenza virus-induced immunogenic cell death to decorate polylactic Coglycolic acid nanoparticles","volume":"19","author":"Yang","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.bbcan.2026.189723_bb0830","doi-asserted-by":"crossref","first-page":"5602","DOI":"10.1021\/acsapm.0c00938","article-title":"Induction of immunogenic cell death in breast Cancer by conductive polymer nanoparticle-mediated photothermal therapy","volume":"2","author":"Huff","year":"2020","journal-title":"ACS Appl. Polym. Mater."},{"key":"10.1016\/j.bbcan.2026.189723_bb0835","doi-asserted-by":"crossref","first-page":"7546","DOI":"10.7150\/thno.56482","article-title":"Recent strategies for nano-based PTT combined with immunotherapy: from a biomaterial point of view","volume":"11","author":"Huang","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.bbcan.2026.189723_bb0840","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbe.2025.100037","article-title":"Recent progress on the application of heavy metal nanoparticles in radiotherapy sensitization","volume":"18","author":"Ding","year":"2026","journal-title":"Nano Biomed. Eng."},{"key":"10.1016\/j.bbcan.2026.189723_bb0845","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2026.189541","article-title":"Current landscape of PDT-based combination therapy for cutaneous squamous cell carcinoma: from molecular mechanisms to clinical practice","volume":"1881","author":"Kang","year":"2026","journal-title":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"},{"key":"10.1016\/j.bbcan.2026.189723_bb0850","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s40824-022-00308-z","article-title":"Recent advances in near-infrared-II hollow nanoplatforms for photothermal-based cancer treatment","volume":"26","author":"Zhang","year":"2022","journal-title":"Biomater. Res."},{"key":"10.1016\/j.bbcan.2026.189723_bb0855","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/imr.13251","article-title":"Amplifying \"eat me signal\" by immunogenic cell death for potentiating cancer immunotherapy","volume":"321","author":"Xi","year":"2024","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.bbcan.2026.189723_bb0860","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.7150\/thno.80091","article-title":"Strategies targeting PD-L1 expression and associated opportunities for cancer combination therapy","volume":"13","author":"Yin","year":"2023","journal-title":"Theranostics"},{"key":"10.1016\/j.bbcan.2026.189723_bb0865","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1186\/s12951-025-03464-1","article-title":"A minimalist self-assembly nanosystem for cancer immunotherapy via multiple immune activation","volume":"23","author":"Xu","year":"2025","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.bbcan.2026.189723_bb0870","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2025.165523","article-title":"NIR laser activating and camptothecin boosting oxidative stress cascade amplification for high-efficiency synergistic cancer therapy with immune responses activation","volume":"519","author":"Tan","year":"2025","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.bbcan.2026.189723_bb0875","article-title":"Off-photosensitizing derived immuno-photodynamic therapy toward postoperative care","volume":"35","author":"Li","year":"2025","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.bbcan.2026.189723_bb0880","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1001\/jamaoncol.2015.2756","article-title":"Role of local radiation therapy in cancer immunotherapy","volume":"1","author":"Demaria","year":"2015","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.bbcan.2026.189723_bb0885","first-page":"250","article-title":"Photodynamic therapy of cancer: An update","volume":"61","author":"Agostinis","year":"2011","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bbcan.2026.189723_bb0890","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nri.2016.107","article-title":"Immunogenic cell death in cancer and infectious disease","volume":"17","author":"Galluzzi","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbcan.2026.189723_bb0895","series-title":"Annual Review of Immunology","first-page":"51","article-title":"Immunogenic Cell Death in Cancer Therapy","volume":"31","author":"Kroemer","year":"2013"},{"key":"10.1016\/j.bbcan.2026.189723_bb0900","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/cgt.2013.42","article-title":"Extranodal induction of therapeutic immunity in the tumor microenvironment after intratumoral delivery of Tbet gene-modified dendritic cells","volume":"20","author":"Chen","year":"2013","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.bbcan.2026.189723_bb0905","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1322238","article-title":"Tbet and IL-36\u03b3 cooperate in therapeutic DC-mediated promotion of ectopic lymphoid organogenesis in the tumor microenvironment","volume":"6","author":"Weinstein","year":"2017","journal-title":"OncoImmunology"},{"key":"10.1016\/j.bbcan.2026.189723_bb0910","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1126\/science.355.6330.1220","article-title":"Cancer immunotherapy comes of age","volume":"355","author":"Dance","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.bbcan.2026.189723_bb0915","doi-asserted-by":"crossref","first-page":"6032","DOI":"10.1158\/1538-7445.AM2025-6032","article-title":"Abstract 6032: Intratumoral Tregs restrain the immune response against primary and metastatic cancer","volume":"85","author":"Bockman","year":"2025","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189723_bb0920","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/s41392-025-02326-4","article-title":"Regulatory T cells in homeostasis and disease: molecular mechanisms and therapeutic potential","volume":"10","author":"Wang","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bbcan.2026.189723_bb0925","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1274199","article-title":"Selective reprogramming of regulatory T cells in solid tumors can strongly enhance or inhibit tumor growth","volume":"14","author":"Alfar","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2026.189723_bb0930","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1038\/s41590-023-01504-2","article-title":"Conserved transcriptional connectivity of regulatory T cells in the tumor microenvironment informs new combination cancer therapy strategies","volume":"24","author":"Glasner","year":"2023","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bbcan.2026.189723_bb0935","series-title":"Annual Review of Cancer Biology","first-page":"459","article-title":"Regulatory T cells in Cancer","volume":"4","author":"Plitas","year":"2020"},{"key":"10.1016\/j.bbcan.2026.189723_bb0940","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1126\/science.1202947","article-title":"Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4","volume":"332","author":"Qureshi","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.bbcan.2026.189723_bb0945","doi-asserted-by":"crossref","first-page":"4835","DOI":"10.1038\/s41467-020-18570-x","article-title":"PD-L1 on dendritic cells attenuates T cell activation and regulates response to immune checkpoint blockade","volume":"11","author":"Peng","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2026.189723_bb0950","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.997376","article-title":"PD-1 and CTLA-4 exert additive control of effector regulatory T cells at homeostasis","volume":"14","author":"Pereira","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2026.189723_bb0955","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2023739118","article-title":"Treg-expressed CTLA-4 depletes CD80\/CD86 by trogocytosis, releasing free PD-L1 on antigen-presenting cells","volume":"118","author":"Tekguc","year":"2021","journal-title":"P. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbcan.2026.189723_bb0960","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/s41586-021-03326-4","article-title":"CTLA-4 blockade drives loss of Treg stability in glycolysis-low tumours","volume":"591","author":"Zappasodi","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2026.189723_bb0965","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-024-07956-2","article-title":"Anti-TIGIT antibody improves PD-L1 blockade through myeloid and Treg cells","volume":"633","author":"Guan","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2026.189723_bb0970","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121517","article-title":"Engineered PD-1\/TIGIT dual-activating cell-membrane nanoparticles with dexamethasone act synergistically to shape the effector T cell\/Treg balance and alleviate systemic lupus erythematosus","volume":"285","author":"Guo","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.bbcan.2026.189723_bb0975","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/s41375-021-01301-6","article-title":"Targeting LAG3\/GAL-3 to overcome immunosuppression and enhance anti-tumor immune responses in multiple myeloma","volume":"36","author":"Bae","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.bbcan.2026.189723_bb0980","article-title":"Targeting LAG-3, TIM-3, and TIGIT for cancer immunotherapy","volume":"16","author":"Cai","year":"2023","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bbcan.2026.189723_bb0985","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1002\/ijc.34281","article-title":"CD25: a potential tumor therapeutic target","volume":"152","author":"Peng","year":"2023","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbcan.2026.189723_bb0990","article-title":"New emerging targets in cancer immunotherapy: the role of GITR","volume":"4","author":"Buzzatti","year":"2020","journal-title":"ESMO Open"},{"key":"10.1016\/j.bbcan.2026.189723_bb0995","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120648","article-title":"Phototherapy and anti-GITR antibody-based therapy synergistically reinvigorate immunogenic cell death and reject established cancers","volume":"269","author":"Sun","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.bbcan.2026.189723_bb1000","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2023.102614","article-title":"Novel targets for immune-checkpoint inhibition in cancer","volume":"120","author":"Borgeaud","year":"2023","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.bbcan.2026.189723_bb1005","article-title":"New pathways in immune stimulation: targeting OX40","volume":"5","author":"Silva","year":"2020","journal-title":"ESMO Open"},{"key":"10.1016\/j.bbcan.2026.189723_bb1010","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nrc3258","article-title":"Cancer immunotherapy via dendritic cells","volume":"12","author":"Palucka","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbcan.2026.189723_bb1015","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41577-019-0210-z","article-title":"Dendritic cells in cancer immunology and immunotherapy","volume":"20","author":"Wculek","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbcan.2026.189723_bb1020","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1158\/2159-8290.CD-18-0367","article-title":"Fundamental mechanisms of immune checkpoint blockade therapy","volume":"8","author":"Wei","year":"2018","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bbcan.2026.189723_bb1025","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1056\/NEJMra1703481","article-title":"Immune-related adverse events associated with immune checkpoint blockade","volume":"378","author":"Postow","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbcan.2026.189723_bb1030","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1002\/eji.201847659","article-title":"Targeting Treg cells in cancer immunotherapy","volume":"49","author":"Tanaka","year":"2019","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.bbcan.2026.189723_bb1035","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1158\/1538-7445.AM2025-862","article-title":"Abstract 862: dynamic hydrogel drug delivery systems for enhancing tertiary lymphoid structure formation and maturation","volume":"85","author":"Tang","year":"2025","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189723_bb1040","doi-asserted-by":"crossref","DOI":"10.1016\/j.cclet.2025.111092","article-title":"Personalized tumor vaccines based on carrier-free double-adjuvant nanoparticles and tumor-associated antigens for enhancing immune responses","volume":"36","author":"Wang","year":"2025","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.bbcan.2026.189723_bb1045","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.4049\/jimmunol.1300872","article-title":"High endothelial venule blood vessels for tumor-infiltrating lymphocytes are associated with lymphotoxin beta-producing dendritic cells in human breast cancer","volume":"191","author":"Martinet","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbcan.2026.189723_bb1050","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.immuni.2015.03.015","article-title":"A dendritic-cell-stromal axis maintains immune responses in lymph nodes","volume":"42","author":"Kumar","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.bbcan.2026.189723_bb1055","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/nature10540","article-title":"Dendritic cells control lymphocyte entry to lymph nodes through high endothelial venules","volume":"479","author":"Moussion","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2026.189723_bb1060","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.trecan.2018.02.005","article-title":"Reengineering the physical microenvironment of tumors to improve drug delivery and efficacy: from mathematical modeling to bench to bedside","volume":"4","author":"Stylianopoulos","year":"2018","journal-title":"Trends Cancer"},{"key":"10.1016\/j.bbcan.2026.189723_bb1065","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrclinonc.2018.29","article-title":"Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges","volume":"15","author":"Fukumura","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2026.189723_bb1070","article-title":"The 12-CK score: global measurement of tertiary lymphoid structures","volume":"12","author":"Li","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2026.189723_bb1075","article-title":"Characteristics of tertiary lymphoid structures in primary cancers","volume":"2","author":"Goc","year":"2014","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.bbcan.2026.189723_bb1080","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.immuni.2006.08.022","article-title":"Persistence and responsiveness of immunologic memory in the absence of secondary lymphoid organs","volume":"25","author":"Moyron-Quiroz","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.bbcan.2026.189723_bb1085","doi-asserted-by":"crossref","first-page":"9584","DOI":"10.1021\/acsnano.3c13038","article-title":"Antigen-clustered Nanovaccine achieves Long-term tumor remission by promoting B\/CD 4 T cell crosstalk","volume":"18","author":"Li","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.bbcan.2026.189723_bb1090","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.drudis.2014.04.017","article-title":"Approaches to in vitro tissue regeneration with application for human disease modeling and drug development","volume":"19","author":"Ebrahimkhani","year":"2014","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bbcan.2026.189723_bb1095","doi-asserted-by":"crossref","first-page":"10114","DOI":"10.1073\/pnas.91.21.10114","article-title":"Reversible unfolding of fibronectin type III and immunoglobulin domains provides the structural basis for stretch and elasticity of titin and fibronectin","volume":"91","author":"Erickson","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbcan.2026.189723_bb1100","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.exer.2014.07.018","article-title":"From nano to macro: studying the hierarchical structure of the corneal extracellular matrix","volume":"133","author":"Quantock","year":"2015","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.bbcan.2026.189723_bb1105","doi-asserted-by":"crossref","first-page":"469","DOI":"10.2217\/nnm.10.12","article-title":"Engineering hydrogels as extracellular matrix mimics","volume":"5","author":"Geckil","year":"2010","journal-title":"Nanomedicine"},{"key":"10.1016\/j.bbcan.2026.189723_bb1110","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1021\/cm202640w","article-title":"Peptide- and protein-based hydrogels","volume":"24","author":"Jonker","year":"2012","journal-title":"Chem. Mater."},{"key":"10.1016\/j.bbcan.2026.189723_bb1115","doi-asserted-by":"crossref","first-page":"7416","DOI":"10.1021\/jacs.7b00513","article-title":"Designing peptide and protein modified hydrogels: selecting the optimal conjugation strategy","volume":"139","author":"Fisher","year":"2017","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bbcan.2026.189723_bb1120","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21176176","article-title":"Resisting resistance to immune checkpoint therapy: a systematic review","volume":"21","author":"Haibe","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2026.189723_bb1125","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/s41591-018-0057-z","article-title":"A transcriptionally and functionally distinct PD-1+ CD8+ T cell pool with predictive potential in non-small-cell lung cancer treated with PD-1 blockade","volume":"24","author":"Thommen","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbcan.2026.189723_bb1130","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/d41573-019-00090-z","article-title":"The global pipeline of cell therapies for cancer","volume":"18","author":"Yu","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbcan.2026.189723_bb1135","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.it.2019.02.002","article-title":"The cellular immunotherapy revolution: arming the immune system for precision therapy","volume":"40","author":"Paucek","year":"2019","journal-title":"Trends Immunol."},{"key":"10.1016\/j.bbcan.2026.189723_bb1140","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s41578-019-0148-6","article-title":"Hydrogel microparticles for biomedical applications","volume":"5","author":"Daly","year":"2020","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.bbcan.2026.189723_bb1145","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/nmat4294","article-title":"Accelerated wound healing by injectable microporous gel scaffolds assembled from annealed building blocks","volume":"14","author":"Griffin","year":"2015","journal-title":"Nat. Mater."},{"key":"10.1016\/j.bbcan.2026.189723_bb1150","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1126\/scitranslmed.3003130","article-title":"The PDL1-PD1 axis converts human TH1 cells into regulatory T cells","volume":"3","author":"Amarnath","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bbcan.2026.189723_bb1155","first-page":"326","article-title":"Cryo-shocked cancer cell microgels for tumor postoperative combination immunotherapy and tissue regeneration","volume":"28","author":"Kuang","year":"2023","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.bbcan.2026.189723_bb1160","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.actbio.2022.07.051","article-title":"Particle fraction is a bioactive cue in granular scaffolds","volume":"150","author":"Anderson","year":"2022","journal-title":"Acta Biomater."},{"key":"10.1016\/j.bbcan.2026.189723_bb1165","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.biotechadv.2017.05.006","article-title":"Biocompatibility of hydrogel-based scaffolds for tissue engineering applications","volume":"35","author":"Naahidi","year":"2017","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.bbcan.2026.189723_bb1170","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s40360-016-0099-0","article-title":"Manganese-induced neurotoxicity: a review of its behavioral consequences and neuroprotective strategies","volume":"17","author":"Peres","year":"2016","journal-title":"BMC Pharmacol. Toxicol."},{"key":"10.1016\/j.bbcan.2026.189723_bb1175","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1038\/s41422-020-00395-4","article-title":"Manganese is critical for antitumor immune responses via cGAS-STING and improves the efficacy of clinical immunotherapy","volume":"30","author":"Lv","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.bbcan.2026.189723_bb1180","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jphs.2015.12.002","article-title":"Ameliorative effects of tannic acid on carbon tetrachloride-induced liver fibrosis in vivo and in vitro","volume":"130","author":"Chu","year":"2016","journal-title":"J. Pharmacol. Sci."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X26001952?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X26001952?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T04:48:57Z","timestamp":1790570937000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304419X26001952"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":236,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0304419X26001952"],"URL":"https:\/\/doi.org\/10.1016\/j.bbcan.2026.189723","relation":{},"ISSN":["0304-419X"],"issn-type":[{"value":"0304-419X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tertiary lymphoid structures for anti-tumor immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbcan.2026.189723","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"189723"}}